Adline Chem Lab Ltd

Adline Chem Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Adline Chem Lab Ltd

₹ 14.4 4.96%
13 Jul - close price
kamronlabs.com BSE: 524604
About

Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.[1]

Key Points

Business Overview:[1]
ACLL is in the business of manufacturing pharmaceutical chemicals, fine chemicals,
and agrochemical products.

Website BSE
  • Market Cap ₹ 8.41 Cr.
  • Current Price ₹ 14.4
  • High / Low ₹ 18.1 / 7.60
  • Stock P/E
  • Book Value ₹ -3.03
  • Dividend Yield 0.00 %
  • ROCE -933 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 25.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.08 0.08 0.03 0.00 0.07 0.10 0.07 0.10 0.06 0.03 0.05 0.03 0.08
Operating Profit -0.08 -0.08 -0.03 0.00 -0.07 -0.10 -0.07 -0.10 -0.06 -0.03 -0.05 -0.03 -0.08
OPM %
0.07 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.25 0.00 0.00 0.00 0.01
Interest 0.00 0.00 0.03 0.03 0.00 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.01 -0.08 -0.06 -0.03 -0.04 -0.13 -0.10 -0.13 0.16 -0.06 -0.08 -0.07 -0.11
Tax % 0.00% 0.00% -16.67% -33.33% 0.00% -7.69% -10.00% -7.69% -31.25% -16.67% -12.50% -14.29% -9.09%
-0.01 -0.08 -0.05 -0.02 -0.04 -0.13 -0.09 -0.12 0.21 -0.05 -0.07 -0.06 -0.09
EPS in Rs -0.02 -0.14 -0.09 -0.03 -0.07 -0.22 -0.15 -0.21 0.36 -0.09 -0.12 -0.10 -0.15
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
15.36 16.94 17.18 8.10 5.59 6.59 6.33 0.74 0.00 0.00 0.00 0.00
14.42 16.50 15.97 7.23 5.01 9.91 6.56 1.04 0.80 0.18 0.30 0.15
Operating Profit 0.94 0.44 1.21 0.87 0.58 -3.32 -0.23 -0.30 -0.80 -0.18 -0.30 -0.15
OPM % 6.12% 2.60% 7.04% 10.74% 10.38% -50.38% -3.63% -40.54%
0.08 0.10 0.08 0.21 0.25 0.26 0.00 1.33 -3.35 0.00 0.25 0.01
Interest 0.48 0.44 0.32 0.34 0.07 0.02 0.03 0.01 0.00 0.12 0.16 0.18
Depreciation 0.51 0.09 0.96 0.73 0.73 0.42 1.02 0.35 0.09 0.00 0.00 0.00
Profit before tax 0.03 0.01 0.01 0.01 0.03 -3.50 -1.28 0.67 -4.24 -0.30 -0.21 -0.32
Tax % 33.33% 100.00% 0.00% 100.00% 0.00% 7.43% 0.00% -7.46% 0.00% -10.00% -33.33% -12.50%
0.02 0.01 0.01 0.00 0.03 -3.76 -1.28 0.72 -4.23 -0.27 -0.13 -0.28
EPS in Rs 0.03 0.02 0.02 0.00 0.05 -6.43 -2.19 1.23 -7.23 -0.46 -0.22 -0.48
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: 12%
3 Years: %
TTM: -115%
Stock Price CAGR
10 Years: %
5 Years: 22%
3 Years: 14%
1 Year: -13%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85
Reserves 1.21 1.21 1.19 1.18 1.18 -2.64 -3.92 -3.20 -7.42 -7.22 -7.34 -7.62
9.25 9.01 9.94 11.32 5.35 2.85 2.50 1.32 1.33 1.36 1.49 1.80
2.32 2.34 3.97 5.01 9.46 1.52 1.20 0.91 0.31 0.06 0.08 0.04
Total Liabilities 18.63 18.41 20.95 23.36 21.84 7.58 5.63 4.88 0.07 0.05 0.08 0.07
10.08 10.27 12.68 12.45 11.99 4.78 3.64 4.43 0.00 0.00 0.00 0.00
CWIP 0.20 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
8.35 7.94 8.27 10.91 9.85 2.80 1.99 0.45 0.07 0.05 0.08 0.07
Total Assets 18.63 18.41 20.95 23.36 21.84 7.58 5.63 4.88 0.07 0.05 0.08 0.07

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.39 0.83 2.46 0.89 -0.95 -11.34 -0.29 0.21 0.01 -0.17 -0.23 -0.16
-2.44 -0.21 -3.18 -0.37 -0.28 11.24 0.12 0.00 0.00 0.00 0.00 0.00
2.18 -0.78 0.63 1.04 -0.29 -0.02 -0.03 -0.01 0.00 0.15 0.25 0.16
Net Cash Flow 0.12 -0.15 -0.09 1.56 -1.51 -0.12 -0.21 0.20 0.01 -0.02 0.02 0.00
Free Cash Flow -2.06 0.62 -0.73 0.36 -1.23 -0.10 -0.17 0.21 0.01 -0.17 -0.23 -0.16
CFO/OP 41% 189% 203% 102% -164% 342% 126% -70% -1% 94% 110% 107%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 57.74 53.87 56.30 102.74 135.81 79.20 91.11 34.53
Inventory Days 77.67 46.15 55.54 181.31 832.82 81.53 46.98 197.71 0.00
Days Payable 43.12 41.39 49.24 63.34 436.97 41.89 28.91 342.19
Cash Conversion Cycle 92.30 58.62 62.60 220.71 531.66 118.84 109.18 -109.95
Working Capital Days 24.71 -6.46 -29.53 -139.69 -317.99 -72.00 -66.89 -764.53
ROCE % 3.39% 2.84% 2.00% 1.98% 0.59% -40.35% -23.83% -10.95% 5.90% -933.33%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Manufactured goods share of revenue from operations
%

Log in to view insights

Please log in to see hidden values.

Login
Pharma revenue share of total revenue from operations
%
Number of permanent employees
count
Capsules share of pharma manufactured revenue
%
Injectable share of pharma manufactured revenue
%
Liquid share of pharma manufactured revenue
%
Ointment share of pharma manufactured revenue
%
Tablets share of pharma manufactured revenue
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
28.24% 28.24% 29.61% 29.61% 29.61% 29.61% 29.61% 29.61% 29.61% 25.85% 25.85% 25.85%
71.76% 71.75% 70.40% 70.39% 70.39% 70.39% 70.39% 70.39% 70.38% 74.15% 74.15% 74.14%
No. of Shareholders 18,63818,62818,59518,58418,53618,50918,51418,48118,48818,46818,44618,444

Documents

Announcements

Annual reports